NCT01864798View on ClinicalTrials.gov

A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Breast Neoplasms
Interventions
DRUG

Denosumab

Trial Locations (6)

1000

Institute Jules Bordet, Brussels

1070

Hopital Erasme, Brussels

3000

UZ Leuven, Leuven

3050

Royal Melbourne Hospital, Victoria

5000

CMSE, Namur

7000

CHU Ambroise Paré, Mons

Sponsors

Collaborators (1)

Melbourne Health
All Listed Sponsors
collaborator

Melbourne Health

OTHER

lead

Jules Bordet Institute

OTHER